Sblendorio Glenn
Chief Executive Officer at IVERIC bio, Inc.; President & CFO at MEDICINES CO /DE; Director at FOLD
- Sold, on record
- $23.4M
- Dollars the filings state
- Form 4 sales
- 59
- Latest Jan 3, 2023
- Form 144 notices
- 0
- Proposed sales
- Companies
- 3
- Filed as an executive or holder
Companies
- IVERIC bio, Inc.Chief Executive Officer
- MEDICINES CO /DEPresident & CFO
- FOLDAMICUS THERAPEUTICS, INC.Director
Sales by reason
Form 4 sales per month, last 12 months.
Sales by company
- MEDICINES CO /DE538,127 shares
- IVERIC bio, Inc.332,528 shares
- FOLD41,400 shares
Shares sold, every Form 4 sale on record.
Timeline
- 1 Form 4 sale IVERIC bio, Inc.Plan not statedDec 31 2021
Sold 901 shares at $17.01 ($15k)
Sblendorio Glenn, CEO
Sold 0.3% of holdings ($4.8M position)279,133 shares left0x usual sizeFiling
- 2 Form 4 sale IVERIC bio, Inc.Plan not statedMar 18 +77 days
Sold 3,479 shares at $17.00 ($59k)
Sblendorio Glenn, CEO
Sold 1.2% of holdings ($4.8M position)279,689 shares left0.3x usual sizeFiling
- 3 Form 4 sale IVERIC bio, Inc.Plan not statedMar 25 +7 days
Sold 18,775 shares at $17.06 ($320k)
Sblendorio Glenn, CEO
Sold 6.3% of holdings ($5.1M position)279,689 shares left2.3x usual sizeFiling
- 4 Form 4 sale IVERIC bio, Inc.UnusualApr 1 +7 days
Sold 43,369 shares at $17.47 ($758k)
Sblendorio Glenn, CEO
Sold 13.4% of holdings ($5.6M position)279,689 shares left3.2x usual sizeFiling
- 5 Form 4 sale IVERIC bio, Inc.Plan not statedApr 4 +3 days
Sold 50,000 shares at $18.76 ($938k)
Sblendorio Glenn, CEO
Sold 17.9% of holdings ($5.2M position)229,689 shares left2.7x usual sizeFiling
- 6 Form 4 sale IVERIC bio, Inc.Plan not statedNov 2 +212 days
Sold 50,000 shares at $23.01 ($1.2M)
Sblendorio Glenn, CEO
Sold 21.8% of holdings ($5.3M position)179,689 shares left2.7x usual sizeFiling
- 7 Form 4 sale IVERIC bio, Inc.Plan not statedDec 19 +47 days
Sold 19,457 shares at $21.51 ($419k)
Sblendorio Glenn, CEO
Sold 7.4% of holdings ($5.7M position)244,138 shares left1x usual sizeFiling
- 8 Form 4 sale IVERIC bio, Inc.Plan not statedJan 3 +15 days
Sold 17,447 shares at $20.06 ($350k)
Sblendorio Glenn, Chief Executive Officer
Sold 7.1% of holdings ($4.9M position)228,191 shares left0.9x usual sizeFiling
Every transaction
Loading transactions…
Sales and notices (59)
| Source | ||||||||
|---|---|---|---|---|---|---|---|---|
| Jan 3, 2023 | IVERIC bio, Inc. | Chief Executive Officer | Form 4 sale | 17,447 | $350k | 7.1% | Plan not stated | SEC |
| Dec 19, 2022 | IVERIC bio, Inc. | CEO | Form 4 sale | 19,457 | $419k | 7.4% | Plan not stated | SEC |
| Nov 2, 2022 | IVERIC bio, Inc. | CEO | Form 4 sale | 50,000 | $1.2M | 21.8% | Plan not stated | SEC |
| Apr 4, 2022 | IVERIC bio, Inc. | CEO | Form 4 sale | 50,000 | $938k | 17.9% | Plan not stated | SEC |
| Apr 1, 2022 | IVERIC bio, Inc. | CEO | Form 4 sale | 43,369 | $758k | 13.4% | Unusual | SEC |
| Mar 25, 2022 | IVERIC bio, Inc. | CEO | Form 4 sale | 18,775 | $320k | 6.3% | Plan not stated | SEC |
| Mar 18, 2022 | IVERIC bio, Inc. | CEO | Form 4 sale | 3,479 | $59k | 1.2% | Plan not stated | SEC |
| Dec 31, 2021 | IVERIC bio, Inc. | CEO | Form 4 sale | 901 | $15k | 0.3% | Plan not stated | SEC |
| Dec 27, 2021 | IVERIC bio, Inc. | CEO | Form 4 sale | 58,476 | $980k | 17.3% | Plan not stated | SEC |
| Dec 20, 2021 | IVERIC bio, Inc. | CEO | Form 4 sale | 18,524 | $286k | 5.2% | Plan not stated | SEC |
| Dec 13, 2021 | IVERIC bio, Inc. | Chief Executive Officer | Form 4 sale | 8,293 | $122k | 2.5% | Plan not stated | SEC |
| Apr 2, 2019 | IVERIC bio, Inc. | President and CEO | Form 4 sale | 6,914 | $10k | 9.2% | Plan not stated | SEC |
| Apr 2, 2018 | IVERIC bio, Inc. | President and CEO | Form 4 sale | 6,838 | $18k | 12.4% | Plan not stated | SEC |
| Jan 2, 2018 | IVERIC bio, Inc. | President and CEO | Form 4 sale | 8,089 | $26k | 18.1% | Plan not stated | SEC |
| Jul 5, 2017 | IVERIC bio, Inc. | President and CEO | Form 4 sale | 7,828 | $20k | 24.5% | Unusual | SEC |
| Apr 3, 2017 | IVERIC bio, Inc. | President, CFO and Treasurer | Form 4 sale | 7,388 | $26k | 39.0% | Unusual | SEC |
| Dec 22, 2016 | IVERIC bio, Inc. | EVP, COO & CFO, Treasurer | Form 4 sale | 1,079 | $5k | 100.0% | Unusual | SEC |
| Jun 2, 2016 | IVERIC bio, Inc. | EVP, COO & CFO, Treasurer | Form 4 sale | 671 | $38k | 38.3% | Unusual | SEC |
| Dec 30, 2015 | IVERIC bio, Inc. | Director | Form 4 sale | 2,000 | $160k | 100.0% | Unusual | SEC |
| Sep 3, 2015 | MEDICINES CO /DE | President & CFO | Form 4 sale | 25,000 | $1.1M | 20.0% | Plan not stated | SEC |
| Aug 31, 2015 | MEDICINES CO /DE | President & CFO | Form 4 sale | 114,495 | $4.6M | 53.4% | Unusual | SEC |
| Jul 17, 2015 | IVERIC bio, Inc. | Director | Form 4 sale | 3,000 | $202k | 100.0% | Unusual | SEC |
| Jul 13, 2015 | FOLD | Director | Form 4 sale | 10,000 | $150k | 45.6% | Unusual | SEC |
| Jun 25, 2015 | MEDICINES CO /DE | President & CFO | Form 4 sale | 3,305 | $106k | 3.2% | Plan not stated | SEC |
| Apr 15, 2015 | FOLD | Director | Form 4 sale | 20,000 | $250k | 62.6% | Unusual | SEC |
| Mar 23, 2015 | MEDICINES CO /DE | President & CFO | Form 4 sale | 34,773 | $1.1M | 25.3% | Unusual | SEC |
| Aug 27, 2014 | FOLD | Director | Form 4 sale | 10,000 | $65k | 45.6% | Unusual | SEC |
| Dec 5, 2013 | MEDICINES CO /DE | President & CFO | Form 4 sale | 8,516 | $328k | 6.7% | Plan not stated | SEC |
| Nov 18, 2013 | MEDICINES CO /DE | President & CFO | Form 4 sale | 16,484 | $635k | 12.2% | Unusual | SEC |
| Nov 14, 2013 | MEDICINES CO /DE | President & CFO | Form 4 sale | 1,667 | $63k | 1.4% | Plan not stated | SEC |
| Oct 25, 2013 | MEDICINES CO /DE | President & CFO | Form 4 sale | 25,574 | $913k | 17.6% | Unusual | SEC |
| May 10, 2013 | MEDICINES CO /DE | President & CFO | Form 4 sale | 2,709 | $100k | 2.2% | Plan not stated | SEC |
| Feb 26, 2013 | MEDICINES CO /DE | President & CFO | Form 4 sale | 6,613 | $206k | 7.2% | Unusual | SEC |
| Feb 20, 2013 | MEDICINES CO /DE | President & CFO | Form 4 sale | 2,793 | $91k | 2.9% | Plan not stated | SEC |
| Feb 20, 2013 | MEDICINES CO /DE | Executive VP & CFO | Form 4 sale | 27,552 | $894k | 22.5% | Unusual | SEC |
| Jan 16, 2013 | MEDICINES CO /DE | President & CFO | Form 4 sale | 125,000 | $3.8M | 56.2% | Unusual | SEC |
| Jan 8, 2013 | MEDICINES CO /DE | President & CFO | Form 4 sale | 25,000 | $702k | 20.4% | Unusual | SEC |
| Aug 10, 2012 | MEDICINES CO /DE | President & CFO | Form 4 sale | 33,989 | $854k | 26.0% | Unusual | SEC |
| Jul 25, 2012 | MEDICINES CO /DE | President & CFO | Form 4 sale | 25,000 | $629k | 19.1% | Unusual | SEC |
| Mar 19, 2012 | MEDICINES CO /DE | President & CFO | Form 4 sale | 625 | $13k | 0.6% | Plan not stated | SEC |
| Feb 21, 2012 | MEDICINES CO /DE | Executive VP & CFO | Form 4 sale | 4,744 | $99k | 7.1% | Unusual | SEC |
| Jan 19, 2012 | MEDICINES CO /DE | Executive VP & CFO | Form 4 sale | 625 | $12k | 0.9% | Plan not stated | SEC |
| Dec 19, 2011 | MEDICINES CO /DE | Executive VP & CFO | Form 4 sale | 625 | $12k | 0.9% | Plan not stated | SEC |
| Nov 21, 2011 | MEDICINES CO /DE | Executive VP & CFO | Form 4 sale | 625 | $11k | 0.9% | Plan not stated | SEC |
| Nov 14, 2011 | MEDICINES CO /DE | Executive VP & CFO | Form 4 sale | 3,635 | $71k | 5.2% | Unusual | SEC |
| Oct 19, 2011 | MEDICINES CO /DE | Executive VP & CFO | Form 4 sale | 625 | $12k | 0.9% | Plan not stated | SEC |
| Sep 19, 2011 | MEDICINES CO /DE | Executive VP & CFO | Form 4 sale | 625 | $10k | 0.9% | Plan not stated | SEC |
| Sep 14, 2011 | MEDICINES CO /DE | Executive VP & CFO | Form 4 sale | 625 | $9k | 0.9% | Plan not stated | SEC |
| Jul 19, 2011 | MEDICINES CO /DE | Executive VP & CFO | Form 4 sale | 625 | $10k | 0.9% | Plan not stated | SEC |
| Jun 20, 2011 | MEDICINES CO /DE | Executive VP & CFO | Form 4 sale | 625 | $10k | 0.9% | Plan not stated | SEC |
| May 31, 2011 | MEDICINES CO /DE | Executive VP & CFO | Form 4 sale | 3,724 | $72k | 5.1% | Plan not stated | SEC |
| May 19, 2011 | MEDICINES CO /DE | Executive VP & CFO | Form 4 sale | 1,630 | $28k | 2.2% | Plan not stated | SEC |
| Apr 19, 2011 | MEDICINES CO /DE | Executive VP & CFO | Form 4 sale | 625 | $10k | 0.8% | Plan not stated | SEC |
| Mar 21, 2011 | MEDICINES CO /DE | Executive VP & CFO | Form 4 sale | 4,620 | $74k | 5.8% | Plan not stated | SEC |
| Feb 22, 2011 | MEDICINES CO /DE | Executive VP & CFO | Form 4 sale | 25,679 | $435k | 24.6% | Plan not stated | SEC |
| Mar 3, 2009 | MEDICINES CO /DE | Executive Vice President | Form 4 sale | 3,125 | $31k | 4.4% | Plan not stated | SEC |
| Aug 15, 2008 | FOLD | Director | Form 4 sale | 1,400 | $23k | 9.8% | Plan not stated | SEC |
| Mar 3, 2008 | MEDICINES CO /DE | Executive Vice President | Form 4 sale | 3,125 | $59k | 6.0% | Plan not stated | SEC |
| Mar 5, 2007 | MEDICINES CO /DE | Executive Vice President | Form 4 sale | 3,125 | $79k | 7.2% | Plan not stated | SEC |